BTAI BioXcel Therapeutics, Inc. - Common Stock
$0.84
가격 · 8월 18, 2026
기준 재무 정보 8월 13, 2026
52주 범위
$1–$6
2% of range
애널리스트 평점
BUY
11 analysts
목표 주가
$14
+1574% upside
P/E (TTM)
-0.2
ROE
68.8%
순이익률
-10887.4%
BTAI 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$0.84
시가총액
$23M
P/E (TTM)
-0.2
EPS (TTM)
$-5.73
매출 (TTM)
$642.0K
배당 수익률
—
ROE
68.8%
부채/자본
-1.1
52주 범위
$1 – $6
BTAI 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$642.0K
2022-12-31
→
2025-12-31
EPS
$-5.73
2020-12-31
→
2025-12-31
잉여현금흐름
$-58M
2018-12-31
→
2025-12-31
마진
-10887.4%
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
BTAI
동종업계 중앙값
P/E (TTM)
-0.2
0.8
P/S (TTM)
35.3
6.2
P/B
-0.2
3.0
EV / EBITDA
-2.1
—
Price / FCF (주가 / FCF)
-0.4
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
BTAI
동종업계 중앙값
Operating Margin (영업이익률)
-7860.0%
—
Net Profit Margin (순이익률)
-10887.4%
-1056.6%
ROA
-167.9%
-118.6%
ROE
68.8%
-139.5%
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
BTAI
동종업계 중앙값
Debt / Equity (부채 / 자기자본 비율)
-1.1
—
Current Ratio (유동비율)
0.8
2.1
Quick Ratio (당좌 비율)
0.5
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
BTAI
동종업계 중앙값
Revenue YoY (매출 YoY)
-71.7%
—
Revenue CAGR 3Y (매출 CAGR 3년)
19.6%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
BTAI
동종업계 중앙값
BTAI 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
11 명의 애널리스트
- 적극 매수 2 18.2%
- 매수 7 63.6%
- 보유 1 9.1%
- 매도 1 9.1%
- 적극 매도 0 0.0%
12개월 목표 주가
4 명의 애널리스트 · 2026-08-14
중앙값
$8.50
평균
$14.00
← 모든 목표가 하회
$0.84
저가
$1.00
고가
$38.00
중앙값 목표
$8.50
+916.6%
평균 목표
$14.00
+1574.4%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
1.2%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 3월 31일 | $-0.54 | $-0.84 | 0.30% |
| 2025년 12월 31일 | $-0.58 | $-0.77 | 0.18% |
| 2025년 9월 30일 | $-2.18 | $-1.20 | -0.98% |
| 2025년 6월 30일 | $-2.45 | $-1.89 | -0.56% |
| 2025년 3월 31일 | $-1.50 | $-6.79 | 5.3% |
| 2024년 12월 31일 | $-3.57 | $-6.55 | 3.0% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| BTAI | $36M | -0.3 | -71.7% | -10887.4% | 68.8% | — |
| ELUT | — | 0.8 | -15.0% | 434.2% | -753.4% | 53.7% |
| NXTC | $50M | -0.7 | — | — | -172.9% | — |
| QNCX | $187M | -2.0 | — | — | 700.5% | — |
| BYSI | — | — | — | — | 3.1% | — |
| LTRN | — | -1.9 | — | — | — | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $642.0K | $2M | $1M | $375.0K | |
| Cost of Revenue | $164.0K | $2M | $1M | $20.0K | |
| R&D Expense | $30M | $30M | $84M | $91M | |
| SG&A Expense | $20M | $34M | $83M | $69M | |
| Operating Expenses | $51M | $70M | $173M | $160M | |
| Operating Income | $-50M | $-67M | $-172M | $-160M | |
| Interest Expense | · | · | $13M | $8M | |
| Interest Income | $1M | $3M | $6M | $3M | |
| Other Non-op | $-4M | $20M | $394.0K | $-427.0K | |
| Income Tax | $0 | $0 | $0 | · | |
| Net Income | $-70M | $-60M | $-179M | $-166M | |
| EPS (Basic) | $-5.73 | $-23.51 | $-98.33 | $-5.92 | |
| EPS (Diluted) | $-5.73 | $-23.51 | $-98.33 | $-5.92 | |
| Shares (Basic) | 12,208,000 | 2,535,000 | 1,821,000 | 28,015,000 | |
| Shares (Diluted) | 12,208,000 | 2,535,000 | 1,821,000 | 28,015,000 | |
| EBITDA | $-50M | $-67M | $-172M | · |
대차대조표 24
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $28M | $30M | $65M | $194M | |
| Receivables | $233.0K | $131.0K | $71.0K | $248.0K | |
| Inventory | $722.0K | $679.0K | $2M | $2M | |
| Prepaid Expense | $4M | $5M | $3M | $3M | |
| Other Current Assets | $11M | $1M | $2M | $4M | |
| Current Assets | $45M | $37M | $72M | $203M | |
| PP&E (Net) | $175.0K | $475.0K | $784.0K | $1M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $1M | $885.0K | |
| Other Non-current Assets | $0 | $87.0K | $87.0K | $925.0K | |
| Total Assets | $45M | $38M | $74M | $206M | |
| Accounts Payable | $15M | $16M | $14M | $10M | |
| Accrued Liabilities | $4M | $6M | $12M | $19M | |
| Current Liabilities | $54M | $22M | $27M | $33M | |
| Capital Leases | $0 | $65.0K | $440.0K | $786.0K | |
| Total Liabilities | $140M | $131M | $130M | $129M | |
| Long-term Debt | $110M | $103M | · | · | |
| Total Debt | $110M | $103M | $101M | · | |
| Common Stock | $76.0K | $49.0K | $30.0K | $28.0K | |
| Paid-in Capital | $625M | $557M | $534M | $488M | |
| Retained Earnings | $-720M | $-650M | $-591M | $-412M | |
| Stockholders' Equity | $-95M | $-93M | $-57M | $77M | |
| Liabilities + Equity | $45M | $38M | $74M | $206M | |
| Shares Outstanding | 22,328,000 | 3,102,000 | 1,871,000 | 1,759,000 |
현금 흐름 12
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $3M | $6M | $19M | $17M | |
| Restructuring | $194.0K | $2M | $4M | · | |
| Operating Cash Flow | $-58M | $-72M | $-155M | $-135M | |
| CapEx | $0 | $0 | $20.0K | $139.0K | |
| Investing Cash Flow | $0 | $0 | $-20.0K | $-139.0K | |
| Debt Issued | · | · | · | $99M | |
| Net Debt Issued | $0 | $-2M | · | · | |
| Stock Issued | · | · | $27M | · | |
| Net Stock Activity | · | · | $27M | · | |
| Financing Cash Flow | $57M | $37M | $27M | $96M | |
| Net Change in Cash | $-1M | $-35M | $-129M | $-39M | |
| Free Cash Flow | $-58M | · | $-155M | · |
수익성 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -7860.0% | -2967.6% | -12448.0% | · | |
| Net Margin | -10887.4% | -2630.1% | -12974.9% | · | |
| EBITDA Margin | -7860.0% | -2967.6% | -12448.0% | · | |
| ROA | -167.9% | -106.4% | -128.1% | · | |
| ROE | 68.8% | 66.7% | 368.7% | · |
유동성 및 지급능력 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.7 | 2.6 | · | |
| Quick Ratio | 0.5 | 1.3 | 2.4 | · | |
| Debt / Equity | -1.1 | -1.1 | -1.8 | · | |
| LT Debt / Equity | -0.9 | -1.1 | -1.8 | · | |
| Interest Coverage | · | · | -12.9 | · |
효율성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | |
| Inventory Turnover | 0.2 | 1.6 | 0.6 | · | |
| Receivables Turnover | 3.5 | 22.4 | 8.7 | · |
성장률 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | -71.7% | 64.2% | 268.0% | · | |
| Revenue CAGR 3Y | 19.6% | · | · | · |
가치 평가 (TTM) 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $642.0K | $2M | $1M | $375.0K | |
| Net Income TTM | $-70M | $-60M | $-179M | $-166M | |
| Market Cap | $36M | $19M | $1.41B | · | |
| Enterprise Value | $117M | $91M | $1.45B | · | |
| P/E | -0.3 | -0.3 | -0.5 | -58.1 | |
| P/S | 55.6 | 8.2 | 1023.7 | · | |
| P/B | -0.4 | -0.2 | -25.0 | · | |
| P / Tangible Book | · | · | · | 126.0 | |
| P / Cash Flow | -0.6 | -0.3 | -9.1 | · | |
| P / FCF | -0.6 | · | -9.1 | · | |
| EV / EBITDA | -2.3 | -1.4 | -8.4 | · | |
| EV / FCF | -2.0 | · | -9.3 | · | |
| EV / Revenue | 182.1 | 40.3 | 1049.3 | · | |
| Earnings Yield | -358.1% | -392.9% | -208.3% | -1.7% |
손익계산서 15
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $182.0K | $206.0K | $256.0K | $98.0K | $120.0K | $168.0K | $366.0K | $214.0K | $1M | $582.0K | $376.0K | $341.0K | $457.0K | $206.0K | $238.0K | $137.0K | |
| Cost of Revenue | $22.0K | $283.0K | $32.0K | $11.0K | $107.0K | $14.0K | $831.0K | $1M | $62.0K | $80.0K | $713.0K | $512.0K | $26.0K | $9.0K | $9.0K | $11.0K | |
| R&D Expense | $3M | $3M | $7M | $9M | $10M | $5M | $6M | $5M | $8M | $11M | $10M | $20M | $27M | $28M | $33M | $22M | |
| SG&A Expense | $7M | $7M | $4M | $5M | $6M | $6M | $4M | $8M | $9M | $13M | $10M | $24M | $26M | $24M | $20M | $17M | |
| Operating Expenses | $10M | $10M | $11M | $14M | $16M | $10M | $11M | $16M | $18M | $25M | $20M | $49M | $53M | $51M | $53M | $39M | |
| Operating Income | $-10M | $-10M | $-10M | $-14M | $-16M | $-10M | $-10M | $-15M | $-17M | $-24M | $-20M | $-48M | $-52M | $-51M | $-53M | $-39M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $4M | · | $3M | $3M | $3M | $3M | $4M | |
| Interest Income | $131.0K | $211.0K | $321.0K | $236.0K | $230.0K | $279.0K | $368.0K | $616.0K | $671.0K | $947.0K | $945.0K | $1M | $2M | $2M | $1M | $823.0K | |
| Other Non-op | $-394.0K | $2M | $2M | $-13M | $657.0K | $7M | $3M | $5M | $12M | $32.0K | $108.0K | $-5.0K | $537.0K | $-246.0K | $-480.0K | $62.0K | |
| Net Income | $-15M | $-13M | $-13M | $-31M | $-19M | $-7M | $-11M | $-14M | $-8M | $-27M | $-22M | $-50M | $-54M | $-53M | $-55M | $-42M | |
| EPS (Basic) | $-0.49 | $-0.54 | $0.40 | $-2.18 | $-2.45 | $-1.50 | $-1.17 | $-5.15 | $-3.30 | $-13.89 | $-92.94 | $-1.72 | $-1.83 | $-1.84 | $-1.96 | $-1.49 | |
| EPS (Diluted) | $-0.49 | $-0.54 | $0.40 | $-2.18 | $-2.45 | $-1.50 | $-1.17 | $-5.15 | $-3.30 | $-13.89 | $-92.94 | $-1.72 | $-1.83 | $-1.84 | $-1.96 | $-1.49 | |
| Shares (Basic) | 30,300,000 | 23,571,000 | -14,665,000 | 14,196,000 | 7,843,000 | 4,834,000 | -4,559,000 | 2,649,000 | 2,516,000 | 1,929,000 | -85,250,000 | 29,268,000 | 29,187,000 | 28,616,000 | -55,976,000 | 28,022,000 | |
| Shares (Diluted) | 30,300,000 | 23,571,000 | -14,665,000 | 14,196,000 | 7,843,000 | 4,834,000 | -4,559,000 | 2,649,000 | 2,516,000 | 1,929,000 | -85,250,000 | 29,268,000 | 29,187,000 | 28,616,000 | -28,023,980 | 28,022,000 | |
| EBITDA | $-10M | · | · | $-14M | $-16M | $-10M | · | $-15M | $-17M | $-24M | · | $-48M | $-52M | $-51M | · | $-39M |
대차대조표 24
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $17M | $28M | $36M | $17M | $31M | $30M | $40M | $56M | $74M | $65M | $90M | $128M | $166M | $194M | $232M | |
| Receivables | $82.0K | $216.0K | $233.0K | $0 | $17.0K | · | $131.0K | $3.0K | $812.0K | $378.0K | $71.0K | $735.0K | $431.0K | $283.0K | $248.0K | · | |
| Inventory | $483.0K | $500.0K | $722.0K | $459.0K | $506.0K | $642.0K | $679.0K | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Prepaid Expense | $3M | $4M | $4M | $6M | $5M | $5M | $5M | $4M | $3M | $2M | $3M | $4M | $4M | $5M | $3M | $6M | |
| Other Current Assets | $11M | $12M | $11M | $934.0K | $995.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $5M | $5M | $4M | $2M | |
| Current Assets | $29M | $34M | $45M | $44M | $25M | $38M | $37M | $48M | $64M | $81M | $72M | $99M | $138M | $177M | $203M | $242M | |
| PP&E (Net) | $99.0K | $117.0K | $175.0K | $249.0K | $324.0K | $399.0K | $475.0K | $552.0K | $629.0K | $706.0K | $784.0K | $862.0K | $941.0K | $1M | $1M | $1M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $965.0K | $885.0K | $848.0K | |
| Other Non-current Assets | · | · | $0 | $0 | · | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $925.0K | $925.0K | $925.0K | |
| Total Assets | $29M | $34M | $45M | $45M | $26M | $39M | $38M | $49M | $65M | $82M | $74M | $100M | $140M | $180M | $206M | $245M | |
| Accounts Payable | $19M | $16M | $15M | $16M | $17M | $15M | $16M | $15M | $13M | $17M | $14M | $11M | $11M | $8M | $10M | $6M | |
| Accrued Liabilities | $4M | $6M | $4M | $4M | $5M | $4M | $6M | $10M | $13M | $14M | $12M | $27M | $19M | $17M | $19M | $14M | |
| Current Liabilities | $137M | $55M | $54M | $38M | $33M | $26M | $22M | $26M | $27M | $31M | $27M | $39M | $35M | $29M | $33M | $23M | |
| Capital Leases | · | · | $0 | $0 | · | · | $65.0K | $161.0K | $256.0K | $350.0K | $440.0K | $529.0K | $617.0K | $703.0K | $786.0K | $868.0K | |
| Total Liabilities | $144M | $140M | $140M | $134M | $133M | $129M | $131M | $135M | $140M | $155M | $130M | $141M | $134M | $127M | $129M | $118M | |
| Long-term Debt | $104M | $100M | $110M | $109M | $109M | $106M | $103M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $104M | · | · | $109M | $109M | $106M | · | $104M | $103M | $102M | · | $99M | $97M | $95M | · | $92M | |
| Common Stock | $31.0K | $27.0K | $76.0K | $73.0K | $60.0K | $59.0K | $49.0K | $42.0K | $40.0K | $34.0K | $30.0K | $29.0K | $29.0K | $29.0K | $28.0K | $28.0K | |
| Paid-in Capital | $632M | $627M | $625M | $619M | $569M | $567M | $557M | $554M | $551M | $545M | $534M | $528M | $524M | $517M | $488M | $484M | |
| Retained Earnings | $-747M | $-733M | $-720M | $-708M | $-677M | $-657M | $-650M | $-639M | $-626M | $-617M | $-591M | $-568M | $-518M | $-464M | $-412M | $-357M | |
| Stockholders' Equity | $-115M | $-106M | $-95M | $-89M | $-108M | $-90M | $-93M | $-86M | $-74M | $-72M | $-57M | $-41M | $6M | $53M | $77M | $127M | |
| Liabilities + Equity | $29M | $34M | $45M | $45M | $26M | $39M | $38M | $49M | $65M | $82M | $74M | $100M | $140M | $180M | $206M | $245M | |
| Shares Outstanding | 31,305,000 | 27,075,000 | 22,328,000 | 19,996,000 | 6,620,000 | 5,468,000 | 3,102,000 | 42,462,000 | 40,383,000 | 33,632,000 | 1,871,000 | 29,273,000 | 29,267,000 | 29,100,000 | 28,147,000 | 28,023,000 |
현금 흐름 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $358.0K | $435.0K | $450.0K | $581.0K | $2M | $180.0K | $-199.0K | $2M | $1M | $3M | $4M | $4M | $6M | $5M | $5M | $4M | |
| Restructuring | · | $0 | $0 | $194.0K | $0 | $0 | $32.0K | $2M | $856.0K | · | $0 | $4M | · | · | · | · | |
| Operating Cash Flow | $-6M | $-12M | $-14M | $-19M | $-13M | $-12M | $-15M | $-16M | $-23M | $-18M | $-27M | $-38M | $-38M | $-52M | $-39M | $-31M | |
| CapEx | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $30M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $25M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $25M | · | · | |
| Financing Cash Flow | $3M | $232.0K | $6M | $38M | $137.0K | $13M | $4M | $454.0K | $5M | $27M | $2M | $0 | $250.0K | $24M | $50.0K | $30M | |
| Net Change in Cash | $-3M | $-12M | $-9M | $19M | $-12M | $1M | $-11M | $-16M | $-18M | $9M | $-25M | $-38M | $-38M | $-28M | $-39M | $-1M |
수익성 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5600.6% | · | · | -14518.4% | -13210.0% | -6011.3% | · | -7146.3% | -1566.7% | -4151.7% | · | -14163.3% | -11469.1% | -24853.4% | · | -28459.8% | |
| Net Margin | -8084.1% | · | · | -31541.8% | -15989.2% | -4317.9% | · | -6378.5% | -751.7% | -4603.3% | · | -14805.3% | -11710.1% | -25629.1% | · | -30514.6% | |
| EBITDA Margin | -5600.6% | · | · | -14518.4% | -13210.0% | -6011.3% | · | -7146.3% | -1566.7% | -4151.7% | · | -14163.3% | -11469.1% | -24853.4% | · | -28459.8% | |
| ROA | -53.9% | · | · | -66.0% | -42.1% | -12.0% | · | -18.3% | -8.1% | -20.4% | · | -29.2% | -27.6% | -27.0% | · | -16.5% | |
| ROE | 13.2% | · | · | 35.4% | 21.1% | 8.9% | · | 21.6% | 24.2% | 276.8% | · | -116.9% | -62.9% | -42.8% | · | -22.4% |
유동성 및 지급능력 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.2 | · | · | 1.2 | 0.8 | 1.5 | · | 1.9 | 2.4 | 2.6 | · | 2.5 | 4.0 | 6.2 | · | 10.3 | |
| Quick Ratio | 0.1 | · | · | 1.0 | 0.5 | 1.2 | · | 1.6 | 2.1 | 2.4 | · | 2.3 | 3.7 | 5.8 | · | 9.9 | |
| Debt / Equity | -0.9 | · | · | -1.2 | -1.0 | -1.2 | · | -1.2 | -1.4 | -1.4 | · | -2.4 | 16.5 | 1.8 | · | 0.7 | |
| LT Debt / Equity | 0.0 | · | · | -1.0 | -0.9 | -1.1 | · | -1.2 | -1.4 | -1.4 | · | -2.4 | 16.5 | 1.8 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -6.7 | · | -14.9 | -16.1 | -15.2 | · | -10.5 |
효율성 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.0 | · | · | 0.0 | 0.1 | 0.0 | · | 0.7 | 0.0 | 0.0 | · | 0.3 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 3.7 | · | · | 65.3 | 0.3 | · | · | 0.6 | 1.8 | 1.8 | · | 0.9 | 2.1 | 1.5 | · | · |
가치 평가 (TTM) 12
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $606.0K | $592.0K | · | $600.0K | $2M | $2M | · | $2M | $2M | $2M | · | $1M | · | · | · | · | |
| Net Income TTM | $-78M | $-70M | · | $-71M | $-48M | $-56M | · | $-99M | $-139M | $-184M | · | $-199M | $-186M | $-164M | · | $-138M | |
| Market Cap | $44M | · | · | $51M | $12M | $11M | · | $414M | $827M | $1.52B | · | $1.18B | $3.12B | $8.69B | · | $5.30B | |
| Enterprise Value | $136M | · | · | $124M | $103M | $86M | · | $478M | $874M | $1.54B | · | $1.19B | $3.09B | $8.62B | · | $5.16B | |
| P/E | -0.2 | -0.2 | · | -0.2 | -0.1 | -0.1 | · | -0.4 | -1.0 | -2.3 | · | -5.9 | -16.4 | -51.5 | · | -38.4 | |
| P/S | 72.8 | · | · | 85.3 | 7.5 | 5.4 | · | 184.9 | 332.9 | 956.8 | · | 1038.5 | · | · | · | · | |
| P/B | -0.4 | · | · | -0.6 | -0.1 | -0.1 | · | -4.8 | -11.1 | -21.0 | · | -29.2 | 531.8 | 163.9 | · | 41.7 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 531.8 | 163.9 | · | 41.7 | |
| P / Cash Flow | · | · | · | · | · | -0.9 | · | · | · | -85.7 | · | · | · | -166.0 | · | · | |
| EV / EBITDA | -13.3 | · | · | -8.7 | -6.5 | -8.5 | · | -31.3 | -50.5 | -63.9 | · | -24.7 | -58.9 | -168.3 | · | -132.3 | |
| EV / Revenue | 224.0 | · | · | 206.9 | 64.3 | 41.4 | · | 213.5 | 351.8 | 974.1 | · | 1046.5 | · | · | · | · | |
| Earnings Yield | -401.4% | -497.8% | · | -440.6% | -685.1% | -1174.4% | · | -246.5% | -101.3% | -42.7% | · | -17.0% | -6.1% | -1.9% | · | -2.6% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $642.0K | $2M | $1M | $375.0K | — |
| 영업이익률 % | -7860.0% | -2967.6% | -12448.0% | — | — |
| 순이익 | $-70M | $-60M | $-179M | $-166M | $-107M |
| 희석 EPS | $-5.73 | $-23.51 | $-98.33 | $-5.92 | $-4.05 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | -1.1 | -1.1 | -1.8 | — | — |
| 유동비율 | 0.8 | 1.7 | 2.6 | — | 14.2 |
| 당좌 비율 | 0.5 | 1.3 | 2.4 | — | 14.0 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-58M | — | $-155M | — | $-83M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 50개의 제출자 · $8.5M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 14 (+9 이전 분기 대비) | 3 (-5 이전 분기 대비) | 7 (-2 이전 분기 대비) | 9 (+3 이전 분기 대비) | +725K |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
회사 내부자 19 명의 내부자 · 6 임원 · 9 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Vimal Mehta | CEO and President | 2026년 6월 15일 M | 69,817 | 0 | 1 | $-21,167 |
| Richard I Steinhart | Chief Financial Officer | 2026년 6월 15일 M | 26,335 | 0 | 1 | $-7,393 |
| Javier Rodriguez | Chief Legal Officer, Senior Vice President and Corporate Secretary | 2026년 6월 15일 M | 26,838 | 0 | 1 | $-7,085 |
| Frank Yocca | Chief Scientific Officer | 2026년 6월 15일 M | 26,210 | 0 | 1 | $-7,393 |
| William P Kane Jr | Chief Commercial Officer | 2021년 8월 16일 A | — | 0 | 0 | $0 |
| Reina Benabou | Senior Vice President Clinical Research Neuroscience and Chief Development Officer | 2020년 6월 22일 A | — | 0 | 0 | $0 |
| June Bray | 이사 | 2026년 1월 9일 A | — | 0 | 0 | $0 |
| Sandeep Laumas | 이사 | 2026년 1월 9일 A | — | 0 | 0 | $0 |
| David J. Mack | 이사 | 2026년 1월 9일 A | 20,317 | 0 | 0 | $0 |
| Michal Votruba | 이사 | 2026년 1월 9일 A | — | 0 | 0 | $0 |
| Rajiv Patni | 이사 | 2026년 1월 9일 A | — | 0 | 0 | $0 |
| Peter Mueller | 이사 | 2026년 1월 9일 A | 90,000 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | 이사 | 2026년 1월 9일 A | — | 0 | 0 | $0 |
| Krishnan Nandabalan | 이사 | 2023년 4월 6일 M | 0 | 0 | 0 | $0 |
| Susan E. Atkins | — | 2026년 8월 12일 A | — | 0 | 0 | $0 |
| Matthew T. Wiley | — | 2024년 7월 22일 A | 19,011 | 0 | 0 | $0 |
| Vincent O'Neill | — | 2024년 7월 22일 A | 19,957 | 0 | 0 | $0 |
| BioXcel Holdings, Inc. | — | 2021년 6월 25일 S | 8,546,750 | 0 | 0 | $0 |
| BioXcel Corp | — | 2021년 6월 25일 S | 8,546,750 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 2 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| BioXcel LLC, BioXcel Holdings, Inc., Vimal Mehta ×2 제출 서류 | 2024년 6월 6일 | — | 최초 제출 | — | SEC |
| DNCA FINANCE S.C.S ×4 제출 서류 | 2020년 3월 6일 | — | 최초 제출 | 수동적 투자 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 3 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.